医学辅助生殖与心理健康:基于芬兰登记数据的24年纵向分析
该研究利用1995-2018年芬兰登记数据,比较自然受孕分娩、医学辅助生殖后分娩及接受医学辅助生殖但未活产三组女性在参考日期前后各12年内购买精神药物的概率。结果显示未活产组购买精神药物比例持续较高,而两种分娩途径女性使用模式相似。
要点
- 接受医学辅助生殖未活产女性12年后购买精神药物比例为17.73%(95%CI 16.82-18.63),高于自然受孕分娩者11.11%(95%CI 10.98-11.26)及医学辅助生殖后分娩者12.17%(95%CI 11.65-12.69)。
- 自然受孕与医学辅助生殖后分娩女性从受孕前3年至后4年及长期的精神药物使用模式非常相似。
- 作者认为未活产组较高的精神药物使用更可能由非自愿无子女驱动,而非治疗相关压力所致。
核心结论
- 活产女性无论自然受孕还是经医学辅助生殖,其精神药物购买模式相似;接受医学辅助生殖后仍未活产者精神药物使用更高,可能更多源于非自愿无子女而非治疗相关压力。
- 结果强调对接受医学辅助生殖治疗的女性进行咨询的重要性,尤其是在其尝试受孕未成功时。
研究设计与样本
- 基于芬兰1995-2018年登记数据的纵向分析,随访至参考日期前12年和后12年。
- 参考日期:首次活产者为受孕日期(自然或医学辅助受孕),截至2017年底无活产者为末次医学辅助生殖治疗日期。
- 比较三组女性:自然受孕后分娩、医学辅助生殖后分娩、接受医学辅助生殖但未活产。
- 采用线性概率模型估计精神药物(抗抑郁药、抗焦虑药、催眠药和镇静药)购买概率,并在调整社会人口学特征前后分别估计。
主要发现
- 参考日期后12年,接受医学辅助生殖但未活产女性中17.73%(95%CI 16.82-18.63)购买精神药物,自然受孕分娩女性为11.11%(95%CI 10.98-11.26),医学辅助生殖后分娩女性为12.17%(95%CI 11.65-12.69)。
- 接受医学辅助生殖但未活产女性购买精神药物多于自然受孕或医学辅助生殖后分娩女性,且差异随时间未减弱。
- 自然受孕与医学辅助生殖后分娩女性从受孕前3年至受孕后4年及长期的精神药物使用模式非常相似。
- 调整女性社会人口学特征未改变结果。
临床怎么用
- 作者认为结果强调对接受医学辅助生殖治疗的女性进行咨询的重要性,尤其是在其尝试受孕未成功时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medically assisted reproduction can negatively affect women's mental health, particularly when the treatments do not result in a live birth. Although the number of women relying on medically assisted reproduction to conceive has grown rapidly, our knowledge about the mental health effects before, during, and after treatment is limited. OBJECTIVE: This study aimed to understand the long-term association between medically assisted reproduction and mental health outcomes for women before, during, and after their treatments, and according to whether the treatment resulted in a live birth. STUDY DESIGN: Using Finnish register data for the period from 1995 to 2018, we estimated the probability of psychotropic purchases (antidepressants, anxiolytics, hypnotics, and sedatives) for 3 groups of women who: (1) gave birth after natural conception, (2) gave birth after medically assisted reproduction treatments, or (3) underwent medically assisted reproduction but remained childless. We followed up women for up to 12 years before and 12 years after the reference date, which corresponded to the conception date for women who had a first live birth either after a natural or a medically assisted conception, or the date of the last medically assisted reproduction treatment for women with no live birth by the end of 2017. We estimated linear probability models before and after adjustment for sociodemographic characteristics. RESULTS: The results show that women who did not have a live birth after undergoing medically assisted reproduction treatments purchased more psychotropics than women who gave birth after conceiving naturally or through medically assisted reproduction, and that these differences did not attenuate over time. Twelve years after the reference date, 17.73% (95% confidence interval, 16.82-18.63) of women who underwent medically assisted reproduction but remained childless purchased psychotropics vs 11.11% of women who gave birth after natural conception (95% confidence interval, 10.98-11.26) and 12.17% (95% confidence interval, 11.65-12.69) of women who gave birth after medically assisted reproduction treatments. In addition, women who conceived naturally and through medically assisted reproduction had very similar psychotropic use patterns from 3 years before conception to 4 years after, and over the long term. Adjustment for women's sociodemographic characteristics did not change the results. CONCLUSION: The similarities in psychotropic purchases of women who had a live birth, whether naturally or through medically assisted reproduction, suggest that the higher psychotropic use among women who remained childless after undergoing medically assisted reproduction were likely driven more by involuntary childlessness than by treatment-related stress. The results highlight the importance of counseling for women undergoing medically assisted reproduction treatments, especially if their attempts to conceive are unsuccessful.
引用
- Goisis A, Palma M, Metsä-Simola N, et al. Medically assisted reproduction and mental health: a 24-year longitudinal analysis using Finnish register data. Am J Obstet Gynecol. 2022. PMID: 36336083. doi:10.1016/j.ajog.2022.10.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。